Ethics disclosures

ARPA-H Director Endorsed FDA Hormone Therapy Policy While Holding Stock in Evernow, ProPublica Reports

ProPublica reports that ARPA-H Director Alicia Jackson praised an HHS policy change on hormone therapy warnings while holding at least $115,000 in stock in Evernow, a menopause-treatment company she founded, and she has since been placed on administrative leave.